Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-12-14
pubmed:abstractText
Sclerostin is an osteocyte-derived negative regulator of bone formation. It inhibits BMP-stimulated bone formation both in vitro and in vivo but has no direct effect on BMP signaling. Instead, sclerostin inhibits Wnt signaling that is required for BMP-stimulated osteoblastic differentiation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0884-0431
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-28
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17032150-Animals, pubmed-meshheading:17032150-Bone Development, pubmed-meshheading:17032150-Bone Morphogenetic Protein 4, pubmed-meshheading:17032150-Bone Morphogenetic Proteins, pubmed-meshheading:17032150-Cells, Cultured, pubmed-meshheading:17032150-Electroporation, pubmed-meshheading:17032150-Gene Expression Regulation, pubmed-meshheading:17032150-Genes, Reporter, pubmed-meshheading:17032150-Genetic Markers, pubmed-meshheading:17032150-Glycoproteins, pubmed-meshheading:17032150-Humans, pubmed-meshheading:17032150-Mesoderm, pubmed-meshheading:17032150-Mice, pubmed-meshheading:17032150-Muscle, Skeletal, pubmed-meshheading:17032150-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:17032150-Recombinant Proteins, pubmed-meshheading:17032150-Signal Transduction, pubmed-meshheading:17032150-Transfection, pubmed-meshheading:17032150-Wnt Proteins
pubmed:year
2007
pubmed:articleTitle
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation.
pubmed:affiliation
Department of Endocrinology and Metabolic Diseases, Leiden Univerity Medical Center, Ther Netherlands. R.L.van_Bezooyen@lumc.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't